EMPIRICO
Live / Registered — Registered — Section 8 accepted (as of 29 Nov 2025)
What this means for you
Registered since 21 Jul 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88246067
- Registration number
- 6109523
- Mark type
- Stylized text
- Filed
- 31 Dec 2018
- Registered
- 21 Jul 2020
- Attorney of record
- Chelsea E. Carbone
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research in connection with human genetics and programmable biology; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research in the fields of pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research in the field of treatment of infectious, deficiency, hereditary, and physiological diseases; medical research in connection with various diseases and disorders, including eosinophilic diseases, asthma, CRS, and allergic rhinitis, autoimmune diseases, including psoriasis, vitiligo, and lichen planus, ocular diseases, including intraocular pressure and glaucoma, and atopic dermatitis
Owner
- Empirico Inc., San Diego, CA, US
- Empirico Inc., San Diego, CA, US
Prosecution history
- 29 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 29 Nov 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 29 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Jul 2025 — TEAS SECTION 8 RECEIVED
- 21 Jul 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Jul 2020 — REGISTERED-SUPPLEMENTAL REGISTER
- 17 Jun 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 10 Jun 2020 — ASSIGNED TO LIE
- 02 Jun 2020 — ASSIGNED TO LIE
- 28 May 2020 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 27 May 2020 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 27 May 2020 — USE AMENDMENT ACCEPTED
- 28 Apr 2020 — AMENDMENT TO USE PROCESSING COMPLETE
- 03 Apr 2020 — USE AMENDMENT FILED
- 28 Apr 2020 — DIVISIONAL PROCESSING COMPLETE